Whitepaper
20 Aug 2019
Interview with Dr K Anand Kumar, Managing director of Indian Immunologicals Limited
PDF 381 kB
An interview with Dr K Anand Kumar, Managing director, Indian Immunologicals Limited regarding the company's future growth plans & current R&D pipeline.
Content provided by our supplier
Indian Immunologicals Ltd
-
IN
-
2019On CPHI since
-
1000 - 4999Employees
Company types
Other Content from Indian Immunologicals Ltd (2)
-
News COVID-19 VACCINE DEVELOPMENT
Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world.
Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance